Literature DB >> 8738975

The paradoxical effects of interleukin 10 in the immunoregulation of autoimmune diabetes.

B Balasa1, N Sarvetnick.   

Abstract

Insulin-dependent diabetes mellitus (IDDM) is a chronic autoimmune disease and spontaneously develops in NOD mice and humans. The role of T helper 1 (Th1) and T helper 2 (Th2) cytokines in the immunopathogenesis of disease is not understood. IL-10 has presented a particularly paradoxical role. Transgenic (Tg) BALB/c mice expressing IL-10 in the pancreas exhibited periinsulitis but not insulitis and diabetes. However, backcrossing of these Tg mice with NOD mice accelerated the onset of diabetes, indicating a pathogenic role for IL-10 in the pathogenesis of autoimmune diabetes since it is able to replace the genetic susceptibility information on the NOD genome. Conversely, administration of IL-10 to adult NOD delayed the onset of and decreased the incidence of diabetes suggesting a potential therapeutic role for IL-10 in autoimmune diabetes. Overall, the findings indicated a paradoxical role for IL-10 in the immunoregulation of autoimmune diabetes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8738975     DOI: 10.1006/jaut.1996.0036

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  12 in total

Review 1.  Type I (insulin-dependent) diabetes is a Th1- and Th2-mediated autoimmune disease.

Authors:  S T Azar; H Tamim; H N Beyhum; M Z Habbal; W Y Almawi
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice.

Authors:  K Goudy; S Song; C Wasserfall; Y C Zhang; M Kapturczak; A Muir; M Powers; M Scott-Jorgensen; M Campbell-Thompson; J M Crawford; T M Ellis; T R Flotte; M A Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

Review 3.  The paradigm of Th1 and Th2 cytokines: its relevance to autoimmunity and allergy.

Authors:  V K Singh; S Mehrotra; S S Agarwal
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

4.  Treatment of autoimmune diabetes recurrence in non-obese diabetic mice by mouse interferon-beta in combination with an analogue of 1alpha,25-dihydroxyvitamin-D3.

Authors:  C Gysemans; E Van Etten; L Overbergh; A Verstuyf; M Waer; R Bouillon; C Mathieu
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

5.  Autoantigens plus interleukin-10 suppress diabetes autoimmunity.

Authors:  Béla Dénes; István Fodor; William H R Langridge
Journal:  Diabetes Technol Ther       Date:  2010-08       Impact factor: 6.118

6.  Time course and cellular localization of interleukin-10 mRNA and protein expression in autoimmune inflammation of the rat central nervous system.

Authors:  S Jander; J Pohl; D D'Urso; C Gillen; G Stoll
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

7.  Gamma interferon is not required for arthritis resistance in the murine Lyme disease model.

Authors:  L Glickstein; M Edelstein; J Z Dong
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

8.  Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis.

Authors:  S Melgar; M M-W Yeung; A Bas; G Forsberg; O Suhr; A Oberg; S Hammarstrom; A Danielsson; M-L Hammarstrom
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

Review 9.  Treatment of Type 1 diabetes with anti-CD3 monoclonal antibody: induction of immune regulation?

Authors:  Kevan C Herold; Lesley Taylor
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

10.  Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis.

Authors:  D J Cua; H Groux; D R Hinton; S A Stohlman; R L Coffman
Journal:  J Exp Med       Date:  1999-03-15       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.